Revision total joint arthroplasty (TJA) is increasing in frequency over time and is associated with a higher risk of morbidity and mortality compared to primary TJA. Common indications for revision TJA include periprosthetic joint infection, aseptic loosening, component malposition, periprosthetic fracture, instability/dislocation, total knee arthroplasty (TKA) stiffness, and total hip arthroplasty (THA) prosthetic taper corrosion. These are challenging clinical scenarios, often with limited treatment options. It is thus important to develop techniques through clinical and basic science investigation for the prevention of these conditions, when possible, or administration of more effective, durable treatments.
We welcome original research and review articles addressing current dilemmas in revision TJA. The potential topics include, but are not limited to, the following:
- Debridement, antibiotics, and implant retention (DAIR) for acute infection;
- Single-stage, 1.5-stage, or two-stage revision for chronic infection;
- Reconstruction of bone defects, prosthesis selection, and survival;
- Surgical approaches and intraoperative techniques;
- Medical preoperative optimization and postoperative management;
- Risks factors for reoperation or other adverse events;
- Biomechanical analysis of implant-bone constructs;
- Basic science elucidation of infection, arthrofibrosis, osteolysis, or adverse local tissue reaction pathogenesis.
Submissions of both commissioned and non-commissioned content should be formatted according to the journal’s guidelines. All manuscripts will undergo standard peer review and must be submitted through Editorial Manager.
Submission Deadline: February 1, 2024